US 6894068
Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
expired A61PA61P31/18A61P37/04
Quick answer
US patent 6894068 (Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P31/18, A61P37/04, A61P43/00